During the past decade, Instituto Reumatologico Strusberg conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 7 clinical trials were completed, i.e. on average, 87.5% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 5 clinical trials were completed. i.e. 166.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Instituto Reumatologico Strusberg" #1 sponsor was "Eli Lilly and Company" with 4 trials, followed by "Bristol-Myers Squibb" with 3 trials sponsored, "Hoffmann-La Roche" with 2 trials sponsored, "EMD Serono Research & Development Institute, Inc." with 1 trials sponsored and "Galapagos NV" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Instituto Reumatologico Strusberg" #1 collaborator was "Gilead Sciences" with 1 trials as a collaborator and "Merck KGaA, Darmstadt, Germany" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Instituto Reumatologico Strusberg" are "Rheumatoid Arthritis" (6 trials), "Arthritis" (1 trials), "Autoimmune Diseases" (1 trials), "Connective Tissue Diseases" (1 trials) and "Diabetes Mellitus, Type 2" (1 trials). Many other conditions were trialed in "Instituto Reumatologico Strusberg" in a lesser frequency.

Most popular intervention types in "Instituto Reumatologico Strusberg" are "Drug" (10 trials), "Biological" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (7 trials), "Abatacept" (2 trials), "BMS-986142" (1 trials), "Baricitinib" (1 trials) and "Dulaglutide" (1 trials). Other intervention names were less common.

The vast majority of trials in "Instituto Reumatologico Strusberg" are 11 trials for "All" genders.

Currently, there are NaN active trials in "Instituto Reumatologico Strusberg". undefined are not yet recruiting, 3 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in Instituto Reumatologico Strusberg, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Instituto Reumatologico Strusberg, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".